FR reports equity from Carta Healthcare and HealthPals, and consulting fees from HealthPals, Novartis, NovoNordisk, Esperion Therapeutics, Movano Health, Kento Health, Inclusive Health, Edwards, Arrowhead Pharmaceuticals, and HeartFlow outside the submitted work
Kelleni MT, Amin EF, Abdelrahman AM
Pharmaceutical Effects Ben notes the GLP-1 supplement space has been challenging for nutraceuticals to navigate meaningfully
In the STEP 1 semaglutide extension, participants regained about two-thirds of their prior weight loss within one year after withdrawal
This is precisely why dermatologists cycle hydroquinone use rather than prescribing it continuously, and why many now prefer starting with alpha arbutin for Indian skin